589 related articles for article (PubMed ID: 8669811)
1. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro.
Shamsuddin AM; Yang GY; Vucenik I
Anticancer Res; 1996; 16(6A):3287-92. PubMed ID: 9042302
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
4. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).
Sakamoto K; Venkatraman G; Shamsuddin AM
Carcinogenesis; 1993 Sep; 14(9):1815-9. PubMed ID: 7691427
[TBL] [Abstract][Full Text] [Related]
6. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Schaider H; Haberkorn U; Stöhr M; Berger MR
Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814
[TBL] [Abstract][Full Text] [Related]
7. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L
Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and cellular functions of IP6: a review.
Shamsuddin AM
Anticancer Res; 1999; 19(5A):3733-6. PubMed ID: 10625949
[TBL] [Abstract][Full Text] [Related]
9. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
10. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
[TBL] [Abstract][Full Text] [Related]
11. Protection against cancer by dietary IP6 and inositol.
Vucenik I; Shamsuddin AM
Nutr Cancer; 2006; 55(2):109-25. PubMed ID: 17044765
[TBL] [Abstract][Full Text] [Related]
12. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells.
Schroy PC; Rustgi AK; Ikonomu E; Liu XP; Polito J; Andry C; O'Keane JC
J Cell Physiol; 1994 Oct; 161(1):111-23. PubMed ID: 7929596
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin.
Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM
Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638
[TBL] [Abstract][Full Text] [Related]
14. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.
Schröterová L; Hasková P; Rudolf E; Cervinka M
Oncol Rep; 2010 Mar; 23(3):787-93. PubMed ID: 20127021
[TBL] [Abstract][Full Text] [Related]
15. Stereospecificity of inositol hexakisphosphate dephosphorylation by Paramecium phytase.
Van der Kaay J; Van Haastert PJ
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):907-10. PubMed ID: 8554537
[TBL] [Abstract][Full Text] [Related]
16. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
Barnard JA; Warwick G
Cell Growth Differ; 1993 Jun; 4(6):495-501. PubMed ID: 8373733
[TBL] [Abstract][Full Text] [Related]
17. Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells.
Shamsuddin AM; Yang GY
Carcinogenesis; 1995 Aug; 16(8):1975-9. PubMed ID: 7634429
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
19. Inositol phosphates have novel anticancer function.
Shamsuddin AM
J Nutr; 1995 Mar; 125(3 Suppl):725S-732S. PubMed ID: 7884558
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
